Funded Tech Companies
Remedium Bio
Wondering who invested in Remedium Bio? Primo Medical Group, Apis Health Angels and Longevitytech.fund joined the equity holders in this innovative biopharmaceutical company.
Company Overview
Company Name
Remedium Bio
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
1116 Great Plain Ave 203
Needham, MA 02492
USA
Needham, MA 02492
USA
Phone
Website
Email Address
Company Background Information
Overview
Remedium Bio is a Boston based gene therapy company focused on the development of highly innovative treatments for a broad range of diseases. The Remedium approach utilizes proven scientific fundamentals, in a novel way, to treat the most debilitating conditions. Starting with well-characterized pathophysiological principles, our scientists modularly apply proven technologies to quickly advance curative treatments through the R&D cycle. Today, our leading candidates include gene therapy treatments in the fields of Endocrinology, Cardiology, Hematology, and Rheumatology.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
8/16/2022
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Francesco Luppino
Chief Operating Officer
Alex Goraltchouk
Company Investors
- Primo Medical Group
- Apis Health Angels
- Longevitytech.fund
- Angel Star Ventures
- Guindy Alumni Angels
- Sherwood Ventures
- MicroVentures
Browse more funded tech companies:
Remedify | Remedium Technologies
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs